US$ 27.78
hypoglycemia glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes injectible_hypoglycemic_drugs [TUSOM | Pharmwiki]
Description
Wang W, Wang Q, Wan D, Sun Y, Wang L, Chen H, et al
![hypoglycemia glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes injectible_hypoglycemic_drugs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Patients on anticoagulants should maintain consistent vitamin K intake and discuss any supplement changes with their healthcare provider
![hypoglycemia glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes injectible_hypoglycemic_drugs [TUSOM | Pharmwiki]](https://www.creative-diagnostics.com/blog/wp-content/uploads/2024/01/Effects-of-Glucagon-Like-Peptide-1-Receptor-Agonists-on-Diabetic-Cardiomyopathy.png)
Front Endocrinol (Lausanne) 24(15):1431292
![hypoglycemia glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes injectible_hypoglycemic_drugs [TUSOM | Pharmwiki]](https://www.diabetesincontrol.com/wp-content/uploads/2012/06/www.diabetesincontrol.com_images_issues_2012_06_632_feature_fig1.jpg)
Both drugs carry list prices in the high three-digit to low four-digit dollar range per monthly supply, but manufacturer programs and insurance coverage can shift out-of-pocket expenses significantly
![hypoglycemia glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes injectible_hypoglycemic_drugs [TUSOM | Pharmwiki]](https://www.frontiersin.org/files/Articles/1520313/xml-images/fendo-15-1520313-g001.webp)
The SUSTAIN-6 trial showed cardiovascular benefit, which expanded the label in 2020
![hypoglycemia glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes injectible_hypoglycemic_drugs [TUSOM | Pharmwiki]](https://pbs.twimg.com/media/DyzquPhU8AIIksy.jpg)
The glucagon-like peptide-1 receptor agonist reduces inflammation and bloodbrain barrier breakdown in an astrocyte-dependent manner in experimental stroke